Ȩ
>
¹®ÀÇ
> Q&A°Ô½ÃÆÇ
À̸§
À̸ÞÀÏ
Á¦¸ñ
³»¿ë
One moment, please
hersolution australia
The Swiss group's chief operating officer, Stephan Kutzer,said on Thursday it was now clear that biosimilars would"require more capital than initially planned and will also takemore time until they reach the market".
ºñ¹Ð¹øÈ£
== Á¦ÈÞ¾÷ü ¼Ò°³ ==
¼ººÏ±¸ ±æÀ½Á¡
µ¿´ë¹®±¸ û·®¸®Á¡
¼ÛÆı¸ ½ÅõÁ¡
== ÀϹÝ(ÀÚ·á)°Ô½ÃÆÇ ==
ÀÔÁÖÀÚ Àü¿ë°ø°£
°³¹ßÁ¦ÀÛ ¹®ÀÇ
±¤°í °Ô½ÃÆÇ
¼¿ï½Ã µ¿´ë¹®±¸ Àü³ó2µ¿ 597-6 ÀԽźôµù "¿ÀÇǽº·»Æ®" »ç¾÷ÀÚµî·Ï¹øÈ£ : 205-27-76422, ´ëÇ¥ : À±´öÇö
°í°´»ó´ã : 02-959-6998, 011-9975-8467, E-mail/MSN¸Þ½ÅÀúÁÖ¼Ò : madredneck@yahoo.com